Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07316621Not Yet Recruiting

Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

Role: lead

NCT06727253Not ApplicableRecruiting

Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression

Role: lead

NCT06794281Active Not Recruiting

Synthetic Generation of Hematological Data Over Federated Computing Frameworks: SCD Use Case

Role: collaborator

NCT05420233Not ApplicableRecruiting

The CROCO Study: CROhn's Disease COhort Study

Role: lead

NCT05777291Not ApplicableRecruiting

IntelligentCare: Wearable-based Intervention

Role: lead

All 5 trials loaded